B
Braidwell Portfolio holdings
AUM
$2.92B
This Quarter Return
+4.66%
1 Year Return
-4.59%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.98B
AUM Growth
–
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
56.69%
Top 10 Holdings %
Top 10 Hldgs %
33.01%
Holding
88
New
63
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Glaukos
GKOS
|
$72.6M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$71.5M |
| 3 |
Biogen
BIIB
|
$69.9M |
| 4 |
Vaxcyte
PCVX
|
$65.3M |
| 5 |
Natera
NTRA
|
$65.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 56.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Nkarta
NKTX
$149M
| $9.14M | 0.31% |
+1,525,800
| New | +$9.14M |
|
52
Compass Therapeutics
CMPX
$466M
| $9.13M | 0.31% |
+1,814,266
| New | +$9.13M |
|
53
Dyne Therapeutics
DYN
$1.92B
| $8.73M | 0.29% |
+753,145
| New | +$8.73M |
|
54
Nuvation Bio
NUVB
$1.08B
| $7.92M | 0.27% |
+4,122,900
| New | +$7.92M |
|
|
ALLK
55
DELISTED
Allakos
ALLK
| $7.75M | 0.26% |
+920,304
| New | +$7.75M |
|
56
Alector
ALEC
$282M
| $6.69M | 0.22% |
+725,024
| New | +$6.69M |
|
57
Kodiak Sciences
KOD
$453M
| $6.55M | 0.22% |
+914,209
| New | +$6.55M |
|
|
FUSN
58
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $6.3M | 0.21% |
+2,000,000
| New | +$6.3M |
|
59
Milestone Pharmaceuticals
MIST
$151M
| $4.61M | 0.15% |
+1,164,849
| New | +$4.61M |
|
60
MoonLake Immunotherapeutics
MLTX
$3.78B
| $4M | 0.13% |
+381,120
| New | +$4M |
|
61
ALX Oncology
ALXO
$54.6M
| $2.91M | 0.1% |
+258,280
| New | +$2.91M |
|
62
Nektar Therapeutics
NKTR
$543M
| $1.4M | 0.05% |
+41,352
| New | +$1.4M |
|
|
ITOS
63
DELISTED
iTeos Therapeutics
ITOS
| $1.4M | 0.05% |
+71,585
| New | +$1.4M |
|